#DNA

Study finds that risk of adverse side effects from cancer immunotherapy is higher in patients with certain inherited genetic variations.

A number of mutations can drive myeloproliferative neoplasms.

Scientists map the genetic evolution of chronic lymphocytic leukemia (CLL) to Richter’s Syndrome.

In the near future, it may be possible to design specific diets tailored to individual genomic profiles to starve tumors.

Routine screening can detect colorectal cancer at an early stage, when it’s easier to treat.

A recent study offers good news about non-invasive stool-based colorectal cancer screening tools.

It is estimated that 106,180 new colon cancer cases and 44,850 new rectal cancer cases will be diagnosed in the U.S. this year.

Gavin Ha explains his research on liquid biopsies—blood samples with traces of DNA that provide molecular details about cancer.

Watch these videos to learn how the Prostate Cancer Promise registry aims to identify hereditary DNA mutations.

“This is simply a blood draw.” Analyzing plasma to define gene mutations in breast cancer is less invasive than tissue biopsies.

The technology used to create COVID-19 vaccines may also help treat cancer.

Researchers created a new type of cancer drug that causes lethal DNA damage in the cells of brain tumors called glioblastomas.

A new approach to prognosis looks to patients’ genomes for clues about how their cancer will behave.

Genomic tumor profiling in pediatric patients can clarify diagnosis and treatment, a recent study found.

Artificial intelligence and machine learning can help identify genetic changes that lead to cancer—and which treatments work best.

A new study is investigating the genetic differences that leave Black men more susceptible to prostate cancer.